Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Physiotherapy Department, Alfred Health, Melbourne, VIC, Australia.
Int J Chron Obstruct Pulmon Dis. 2022 Aug 17;17:1871-1882. doi: 10.2147/COPD.S368336. eCollection 2022.
Pulmonary rehabilitation is an effective intervention for people with chronic obstructive pulmonary disease (COPD). People with COPD undertake repeat programs, but synthesis of evidence regarding such practice has not been undertaken. The aim of this systematic review was to establish the effects of repeating pulmonary rehabilitation subsequent to an initial program in people with COPD.
Studies where participants with COPD undertook >1 pulmonary rehabilitation program were included, incorporating RCT (randomized controlled trial) and non-randomized studies. Electronic database searches were undertaken. Two authors independently undertook study identification, data extraction and risk of bias assessment. The primary outcome was health-related quality of life (HRQoL); secondary outcomes were exercise capacity, hospitalizations and exacerbations, adherence, mortality and adverse events. Narrative synthesis was undertaken for clinically heterogeneous trials. Data from RCTs and non-randomized studies were not combined for analysis.
Ten included studies (2 RCTs) involved 907 participants with COPD (n=653 had undertaken >1 program). The majority of studies were at high risk of bias. One RCT (n=33) reported no difference in HRQol after a repeat program vs usual care following exacerbation (Chronic Respiratory Disease Questionnaire dyspnea domain score MD 0.4, 95% CI -0.5 to 3). In stable patients, clinically important and statistically significant improvements in HRQoL and exercise capacity were reported after repeat programs, but of a smaller magnitude than initial programs. There was evidence for reductions in exacerbations and hospitalizations, and shorter hospital length of stay for patients who repeated a program twice in 12 months compared to those who repeated once. No data for mortality or adverse events were available.
This systematic review provides limited evidence for benefits of repeating pulmonary rehabilitation in people with COPD, including improved HRQoL and exercise capacity, and reduced hospitalizations. However, most studies have high risk of bias, which reduces the certainty of these conclusions.
PROSPERO (CRD42020215093).
肺康复是治疗慢性阻塞性肺疾病(COPD)的有效干预措施。COPD 患者会多次进行康复计划,但目前尚未对这种做法进行综合证据评估。本系统评价的目的是确定 COPD 患者在初始康复计划后重复进行康复计划的效果。
纳入参与者接受 >1 次肺康复计划的研究,包括随机对照试验(RCT)和非随机研究。进行电子数据库检索。两名作者独立进行研究筛选、数据提取和偏倚风险评估。主要结局为健康相关生活质量(HRQoL);次要结局为运动能力、住院和加重、依从性、死亡率和不良事件。对临床异质性试验进行叙述性综合分析。未对 RCT 和非随机研究的数据进行合并分析。
10 项纳入研究(2 项 RCT)共纳入 907 例 COPD 患者(n=653 例接受 >1 次康复计划)。大多数研究存在高偏倚风险。1 项 RCT(n=33)报道在加重后接受重复康复计划与常规护理相比,HRQol 无差异(慢性呼吸系统疾病问卷呼吸困难域评分 MD 0.4,95%CI -0.5 至 3)。在稳定期患者中,重复康复计划后 HRQoL 和运动能力有临床意义和统计学意义的改善,但程度小于初始康复计划。重复康复计划两次的患者与重复一次的患者相比,发生加重和住院的次数减少,住院时间缩短。尚无死亡率或不良事件的数据。
本系统评价提供了 COPD 患者重复肺康复的有限证据,包括改善 HRQoL 和运动能力,减少住院。然而,大多数研究存在高偏倚风险,降低了这些结论的确定性。
PROSPERO(CRD42020215093)。